NO20081896L - Retardformulering for pralnacasan - Google Patents

Retardformulering for pralnacasan

Info

Publication number
NO20081896L
NO20081896L NO20081896A NO20081896A NO20081896L NO 20081896 L NO20081896 L NO 20081896L NO 20081896 A NO20081896 A NO 20081896A NO 20081896 A NO20081896 A NO 20081896A NO 20081896 L NO20081896 L NO 20081896L
Authority
NO
Norway
Prior art keywords
pralnacasan
type
retardation
releases
formulation
Prior art date
Application number
NO20081896A
Other languages
English (en)
Other versions
NO339360B1 (no
Inventor
Caren Soennichsen
Roland Wesch
Heiko Meier
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20081896L publication Critical patent/NO20081896L/no
Publication of NO339360B1 publication Critical patent/NO339360B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Abstract

Retardtablettene ifølge oppfinnelsen omfatter minst to lag, hvorav minst ett lag raskt frigir et legemiddel IS 9S (RS, 3S) N-(2-etoksy-5-okso-tetrafuran-3-yl)-6, 10-diokso-9(isokinolin-1-oyl-amino)-1,2,3,4,7,8,9,10-oktahydro-6H-pyridazino [1,2-a][1,2] diazepin-1-karboksamid og/eller saltene eller derivatene derav og/eller syrer frigitt derfra og minst ett lag frigir et legemiddel IS, 9S (RS, 3S)N-(2-etoksy-5-oksotetrafuran-3-yl)-6,10-diokso-9-(isokinolin-1-oyl-amino)-1,2,3,4,7,8,9,10-oktahydro-6H-pyridazino [1,2-a] [1,2]diazepin-1-karboksamid og/eller saltene eller derivatene derav og/eller syrene frigitt derfra på en forsinket måte, for behandling av autoimmune sykdommer, type I og type II diabetes, rheumatoid artritt, osteoartritt og/eller psoriasis.
NO20081896A 2005-10-08 2008-04-21 Formulering med forlenget frigivelse omfattende pralnacasan NO339360B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005048293A DE102005048293A1 (de) 2005-10-08 2005-10-08 Retardformulierung für Pralnacasan
PCT/EP2006/009466 WO2007042160A1 (de) 2005-10-08 2006-09-29 Retardformulierung für pralnacasan

Publications (2)

Publication Number Publication Date
NO20081896L true NO20081896L (no) 2008-04-21
NO339360B1 NO339360B1 (no) 2016-12-05

Family

ID=37764039

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081896A NO339360B1 (no) 2005-10-08 2008-04-21 Formulering med forlenget frigivelse omfattende pralnacasan

Country Status (28)

Country Link
US (1) US8231904B2 (no)
EP (1) EP1937221B1 (no)
JP (1) JP2009511441A (no)
KR (1) KR101362679B1 (no)
CN (1) CN101277683B (no)
AT (1) ATE422354T1 (no)
AU (1) AU2006301573B2 (no)
BR (1) BRPI0617184A2 (no)
CA (1) CA2624838C (no)
CY (1) CY1109131T1 (no)
DE (2) DE102005048293A1 (no)
DK (1) DK1937221T3 (no)
ES (1) ES2322202T3 (no)
HK (1) HK1124531A1 (no)
HR (1) HRP20090254T1 (no)
IL (1) IL190511A (no)
MA (1) MA29803B1 (no)
ME (1) ME01735B (no)
MY (1) MY146552A (no)
NO (1) NO339360B1 (no)
NZ (1) NZ567268A (no)
PL (1) PL1937221T3 (no)
PT (1) PT1937221E (no)
RS (1) RS50777B (no)
RU (1) RU2419419C2 (no)
SI (1) SI1937221T1 (no)
WO (1) WO2007042160A1 (no)
ZA (1) ZA200802031B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2575860T3 (es) 2010-07-09 2016-07-01 Bhv Pharma, Inc. Sistema de administración de liberación inmediata/retardada de combinación para productos farmacéuticos de semivida corta que incluyen remogliflozina
CH705678B1 (de) * 2010-08-13 2016-03-15 Euro Celtique Sa Verwendung von Bindemitteln zur Herstellung von lagerungsstabilen Formulierungen.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
CN1524526A (zh) * 2003-03-02 2004-09-01 颖 王 尼群地平双层缓释制剂
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
CN1579401A (zh) * 2003-08-11 2005-02-16 李亦武 一种止咳平喘药物新剂型及制备方法
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
WO2005048979A2 (en) * 2003-10-06 2005-06-02 Torrent Pharmaceuticals Limited Pharmaceutical composition having casing with multiple micro tablets
WO2005051350A2 (en) * 2003-10-28 2005-06-09 Torrent Pharmaceuticals Limited Water dispersible tablet

Also Published As

Publication number Publication date
CN101277683B (zh) 2013-03-20
KR101362679B1 (ko) 2014-02-13
CN101277683A (zh) 2008-10-01
CA2624838C (en) 2013-11-19
NO339360B1 (no) 2016-12-05
ATE422354T1 (de) 2009-02-15
ME01735B (me) 2010-08-31
ES2322202T3 (es) 2009-06-17
EP1937221B1 (de) 2009-02-11
HRP20090254T1 (en) 2009-06-30
IL190511A (en) 2011-05-31
CA2624838A1 (en) 2007-04-19
MA29803B1 (fr) 2008-09-01
RS50777B (sr) 2010-08-31
CY1109131T1 (el) 2014-07-02
KR20080054394A (ko) 2008-06-17
HK1124531A1 (en) 2009-07-17
PT1937221E (pt) 2009-04-17
NZ567268A (en) 2010-08-27
WO2007042160A1 (de) 2007-04-19
IL190511A0 (en) 2008-11-03
BRPI0617184A2 (pt) 2011-07-12
SI1937221T1 (sl) 2009-06-30
US8231904B2 (en) 2012-07-31
ZA200802031B (en) 2009-08-26
AU2006301573B2 (en) 2013-01-10
RU2008113381A (ru) 2009-10-20
RU2419419C2 (ru) 2011-05-27
DE102005048293A1 (de) 2007-04-12
DK1937221T3 (da) 2009-06-15
DE502006002851D1 (de) 2009-03-26
PL1937221T3 (pl) 2009-06-30
AU2006301573A1 (en) 2007-04-19
MY146552A (en) 2012-08-30
US20080279934A1 (en) 2008-11-13
JP2009511441A (ja) 2009-03-19
EP1937221A1 (de) 2008-07-02

Similar Documents

Publication Publication Date Title
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
ATE488232T1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
WO2007100535A3 (en) Oxyntomodulin derivatives
WO2008015220A8 (en) Granule and orally disintegrating tablet comprising oxycodone
EA201171389A1 (ru) Лекарственная форма
WO2009032898A3 (en) Compact input device
ECSP099320A (es) Compuestos de tetrahidropirrolopiracina sustituida y su aplicación en medicamentos
EA200601759A1 (ru) Композиции рамиприла
NO20075702L (no) Polymersjikt med lav fuktighet i ikke-autoklav fremgangsmate
DOP2010000075A (es) Compuesto inhibidor de glicógeno fosforilasa y composicion farmaceutica del mismo
TW200738440A (en) Prism films for optical applications
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
MX2009010231A (es) Una tableta que tiene estabilidad mejorada con al menos dos ingredientes activos.
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
CR11397A (es) Compuesto inhibidor de fosforilasa de glicogeno y composicion farmaceutica del mismo
NO20081896L (no) Retardformulering for pralnacasan
ATE529877T1 (de) Mechanischer schalter mit gekrümmter doppelschicht
WO2008127382A3 (en) Computational design of ribozymes
ITFI20060255A1 (it) Composizione agrochimica, e metodo di trattamento di vegetali conmprendente la somministrazione di tale composizione
DK2231131T3 (da) Formuleringer af organiske platinforbindelser i tilstedeværelsen af associative polymerer, således opnåede produkter og anvendelser deraf
BRPI0816263A2 (pt) composição farmacêutica que compreende a combinação de acemetacina, metocarbamol e diacereína, útil no tratamento da artrite reumatóide e doenças relacionadas
TH75635EX (th) ถุงมือ
TH88033B (th) แป้นพิมพ์สำหรับคอมพิวเตอร์
TH78641S (th) ช้อน
TH78640S (th) ช้อน

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees